The Future of Parkinson’s Disease Treatments

Posted on by Rebecca Gilbert, MD, Ph.D.

The Parkinson’s Disease Medication Pipeline The pipeline for Parkinson’s disease (PD) medications is extremely crowded these days, with multiple...see more medications at various stages of research development. This is very exciting news for the PD community and is a perfect example of the “hope in progress” part of our organization’s motto. It is thrilling to see […]

Read More

How many people in the US have Parkinson’s disease?

Posted on by Rebecca Gilbert, MD, Ph.D.

How many people have Parkinson’s disease? You may have heard the statistic that there are approximately one million people...see more with Parkinson’s disease (PD) living in the US. That means approximately 1 out of every 336 people are living with PD. That number has increased in past decades and will continue to increase.  With a new […]

Read More

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

Posted on by Rebecca Gilbert, MD, Ph.D.

Exciting New Parkinson’s Disease Research is Underway On September 5, 2024, APDA announced 20 new Parkinson’s disease (PD) research...see more grants, for a total of $ 2.6 million in funding for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease (PD) and to develop new treatments and eventually, a […]

Read More

The Heart of The Matter: Cardiovascular Effects of Parkinson’s Disease

Posted on by Rebecca Gilbert, MD, Ph.D.

It has long been understood that Parkinson’s disease (PD) does not just cause movement, or motor, symptoms, but also...see more causes a litany of non-motor symptoms with effects throughout the body. One of the organ systems that is affected is the cardiac system, encompassing the heart, as well as the major and minor blood vessels.

Read More

What is a DaTscan and should I get one?

Posted on by Rebecca Gilbert, MD, Ph.D.

DaTscan: A test to help in the diagnosis of Parkinson’s What is a DaTscan and how is it performed?...see more In 2011, the Food and Drug Administration (FDA) approved an imaging test to help diagnose Parkinson’s disease (PD) called DaTscan (dopamine transporter scan). In this test, a radioactive tracer, Ioflupane (123I), also known as DaTscan, is injected […]

Read More

Gene therapy for Parkinson’s disease

Posted on by Rebecca Gilbert, MD, Ph.D.

What is gene therapy and can it help people with Parkinson’s? You may have read about efforts to use...see more gene therapy as a treatment for Parkinson’s disease (PD). It’s an exciting prospect and studies are underway, with some positive results so far. Understanding these studies and therapies requires some background information about what genes are […]

Read More

Lewy Bodies, Dementia, and Parkinson’s – What Does it all Mean?

Posted on by Rebecca Gilbert, MD, Ph.D.

Understanding Cognitive Challenges in Parkinson’s Disease: PDD vs. DLB Cognitive challenges are a very common non-motor symptom of Parkinson’s...see more disease (PD). When the cognitive challenges are severe enough to interfere with daily activity, they are known as Parkinson’s disease dementia (PDD). You may have heard of another condition called Dementia with Lewy Bodies (DLB). Although […]

Read More

What Worsens Parkinson’s Disease’s Motor Symptoms?

Posted on by Rebecca Gilbert, MD, Ph.D.

Understanding what factors may worsen Parkinson’s symptoms Many people with Parkinson’s disease (PD) experience variation in their motor symptoms...see more (e.g. tremor, stiffness, slowness, trouble walking, balance difficulties) throughout the day and from one day and the next. This variability is often related to medication dosing, and you and your doctor may focus on adjusting the […]

Read More